Showing codes J9204 (Injection, mogamulizumab-kpkc, 1 mg) — J9258 (Injection, paclitaxel protein-bound particles (teva) not therapeutically equivalent to j9264, 1 mg)

J9204 - Inj mogamulizumab-kpkc, 1 mg
Long description: Injection, mogamulizumab-kpkc, 1 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9205 - Inj irinotecan liposome 1 mg
Long description: Injection, irinotecan liposome, 1 mg
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9206 - Irinotecan injection
Long description: Injection, irinotecan, 20 mg
Code added date: 19980101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9207 - Ixabepilone injection
Long description: Injection, ixabepilone, 1 mg
Code added date: 20090101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9208 - Ifosfamide injection
Long description: Injection, ifosfamide, 1 gram
Code added date: 19900101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9209 - Mesna injection
Long description: Injection, mesna, 200 mg
Code added date: 19900101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9210 - Inj., emapalumab-lzsg, 1 mg
Long description: Injection, emapalumab-lzsg, 1 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9211 - Idarubicin hcl injection
Long description: Injection, idarubicin hydrochloride, 5 mg
Code added date: 19930101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9212 - Interferon alfacon-1 inj
Long description: Injection, interferon alfacon-1, recombinant, 1 microgram
Code added date: 19990101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9213 - Interferon alfa-2a inj
Long description: Injection, interferon, alfa-2a, recombinant, 3 million units
Code added date: 19930101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9214 - Interferon alfa-2b inj
Long description: Injection, interferon, alfa-2b, recombinant, 1 million units
Code added date: 19930101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9215 - Interferon alfa-n3 inj
Long description: Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
Code added date: 19930101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9216 - Interferon gamma 1-b inj
Long description: Injection, interferon, gamma 1-b, 3 million units
Code added date: 19930101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9217 - Leuprolide acetate suspnsion
Long description: Leuprolide acetate (for depot suspension), 7.5 mg
Code added date: 19910101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9218 - Leuprolide acetate injeciton
Long description: Leuprolide acetate, per 1 mg
Code added date: 19900101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9219 - Leuprolide acetate implant
Long description: Leuprolide acetate implant, 65 mg
Code added date: 20010101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9223 - Inj. lurbinectedin, 0.1 mg
Long description: Injection, lurbinectedin, 0.1 mg
Code added date: 20210101.
Code effective date: 20210101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9225 - Vantas implant
Long description: Histrelin implant (vantas), 50 mg
Code added date: 20060101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9226 - Supprelin la implant
Long description: Histrelin implant (supprelin la), 50 mg
Code added date: 20080101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9227 - Inj. isatuximab-irfc 10 mg
Long description: Injection, isatuximab-irfc, 10 mg
Code added date: 20201001.
Code effective date: 20201001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9228 - Ipilimumab injection
Long description: Injection, ipilimumab, 1 mg
Code added date: 20120101.
Code effective date: 20120101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9229 - Inj inotuzumab ozogam 0.1 mg
Long description: Injection, inotuzumab ozogamicin, 0.1 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9230 - Mechlorethamine hcl inj
Long description: Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
Code added date: 19860101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9245 - Inj melpha hydroch nos 50 mg
Long description: Injection, melphalan hydrochloride, not otherwise specified, 50 mg
Code added date: 19950101.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9246 - Inj., evomela, 1 mg
Long description: Injection, melphalan (evomela), 1 mg
Code added date: 20200701.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9247 - Inj, melphalan flufenami 1mg
Long description: Injection, melphalan flufenamide, 1mg
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9248 - Inj melphalan (hepzato) 1 mg
Long description: Injection, melphalan (hepzato), 1 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9249 - Inj, melphalan (apotex) 1 mg
Long description: Injection, melphalan (apotex), 1 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9250 - Methotrexate sodium inj
Long description: Methotrexate sodium, 5 mg
Code added date: 19940101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9255 - Inj, methotrexate (accord)
Long description: Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9258 - Paclitaxel (teva)
Long description: Injection, paclitaxel protein-bound particles (teva) not therapeutically equivalent to j9264, 1 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF